Ginkgo biloba increases blood flow to the brain and acts as an antioxidant, which may modestly improve cognitive function in people with dementia. In healthy adults, however, the evidence for any brain-boosting benefit is essentially zero. The distinction matters: ginkgo appears to help aging or damaged brains compensate, not supercharge a healthy one.
How Ginkgo Affects the Brain
Ginkgo leaf extract contains two groups of active compounds: flavonoids and terpene lactones. Each contributes to brain function in a different way.
The flavonoids are antioxidants. They neutralize reactive oxygen species, the unstable molecules that damage neurons over time and contribute to the buildup of amyloid plaques and tangled tau proteins, both hallmarks of Alzheimer’s disease. By reducing this oxidative damage, ginkgo’s flavonoids help slow the chemical chain reaction that degrades brain tissue.
The terpene lactones work on blood vessels. They stimulate the release of nitric oxide and other relaxing factors in arterial walls, causing vessels to widen. The result is improved blood flow to both the brain and peripheral tissues. Better cerebral blood flow means neurons receive more oxygen and glucose, which is especially relevant when small-vessel disease or aging has restricted supply.
Ginkgo also influences neurotransmitter systems. It inhibits the reuptake of serotonin, dopamine, and norepinephrine, keeping these chemical messengers active longer. It modestly blocks the enzyme that breaks down acetylcholine, the neurotransmitter most closely linked to memory and learning. This enhanced cholinergic transmission is one reason researchers have focused on ginkgo for dementia rather than general cognitive enhancement.
Benefits for People With Dementia
The strongest evidence for ginkgo’s brain effects comes from trials in people with Alzheimer’s disease or other forms of dementia. A meta-analysis of eight clinical trials covering 2,100 individuals found that standardized ginkgo extract improved scores on two widely used cognitive tests (the SKT and ADAS-Cog) in early-stage Alzheimer’s patients after 12 to 24 weeks of daily use at higher doses. In those trials, patients taking ginkgo consistently showed score improvements, while placebo groups either stayed flat or worsened slightly.
At a dose of 240 mg per day, one 24-week randomized controlled trial of 410 outpatients found statistically significant improvements in cognition, psychological symptoms, functional status, and quality of life for both patients and their caregivers. These aren’t dramatic reversals. The effect size is small to moderate. But for a condition with limited treatment options, even modest slowing of decline is clinically meaningful.
German national guidelines and the World Federation of Societies of Biological Psychiatry both recommend the standardized extract EGb 761 as a treatment option for mild to moderate dementia. In Germany, ginkgo medications are available without a prescription but are reimbursed by health insurance when prescribed for dementia, with a reassessment of treatment success required after 12 weeks.
Why It Doesn’t Work for Healthy Brains
If you’re hoping ginkgo will sharpen your memory or focus without any underlying cognitive decline, the data is discouraging. A meta-analysis of trials in healthy individuals found effect sizes that were essentially zero across three key domains: memory (effect size of -0.04), executive function (-0.05), and attention (-0.08). None reached statistical significance. The researchers also checked whether age, dose, duration of supplementation, or sample size changed the picture. Nothing did.
This makes biological sense. Ginkgo’s mechanisms, boosting blood flow, protecting against oxidative damage, preserving neurotransmitter levels, address problems that are minimal in a healthy brain. A young, well-functioning vascular system already delivers adequate blood flow. Antioxidant defenses are intact. Neurotransmitter recycling works normally. Ginkgo essentially repairs or compensates for deficits, so when there’s no deficit, there’s nothing to fix.
How Long Before It Takes Effect
Ginkgo is not a fast-acting supplement. Clinical trials measuring cognitive improvement in dementia patients typically run 12 to 24 weeks before significant changes appear on standardized tests. A quantitative review published in JAMA Neurology confirmed that 3 to 6 months of treatment with 120 to 240 mg daily produced a small but significant effect on objective cognitive measures in Alzheimer’s disease. If you or a family member is trying ginkgo for cognitive decline, expect to commit to at least three months of consistent daily use before evaluating whether it’s helping.
Dosage and Extract Quality
Not all ginkgo supplements are the same. The clinical research almost exclusively uses a standardized extract adjusted to contain 22% to 27% flavone glycosides and 5.4% to 6.6% terpene lactones, with ginkgolic acids kept below 5 parts per million (these are potentially toxic compounds found in raw ginkgo). If a supplement label doesn’t list these percentages, there’s no way to know whether the product matches what was tested in trials.
The most common dosing in studies is 120 mg twice daily or 240 mg once daily. Some older protocols used 40 mg three times per day. The maximum recommended daily intake is 240 mg. One large trial, the Ginkgo Evaluation of Memory study, tested 120 mg twice daily in elderly adults with normal cognition or mild cognitive impairment and found no reduction in dementia incidence, reinforcing that ginkgo works better for existing cognitive decline than for prevention.
Bleeding Risk and Drug Interactions
Ginkgo reduces platelet aggregation, which means it makes blood less likely to clot. For most people taking ginkgo alone, this effect is minor. But combined with anticoagulant medications like warfarin, the risk becomes real. A large study of veterans taking both warfarin and ginkgo found a 38% increase in the risk of a bleeding event compared to warfarin alone (hazard ratio of 1.38). That’s a meaningful jump.
The same concern applies to aspirin and other antiplatelet drugs. If you take any medication that affects blood clotting, or if you’re scheduled for surgery, ginkgo is worth discussing with your prescribing physician before starting. The interaction isn’t theoretical: case reports of spontaneous bleeding in ginkgo users have been documented and confirmed by systematic review.
Other side effects are generally mild. Headache, digestive upset, and dizziness are the most commonly reported. As long as daily intake stays at or below 240 mg of standardized extract, the risk of significant herb-drug interactions beyond anticoagulants remains low.